简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-02-16 17:55 Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide
2016-02-16 15:44 ASTRAZENECA’S COMBINATION OF DURVALUMAB WITH TREMELIMUMAB SHOWS CLINICAL ACTIVITY IN NON-SMALL CELL LUNG CANCER IRRESPECTIVE OF PD-L1 STATUS
2016-02-16 11:32 TOMTEC’s Corporate Brand Identity Change
2016-02-16 09:42 Morinaga Milk's B. longum BB536 Probiotic May Prevent Intestinal Disorders Induced by Animal-Based Diet
2016-02-15 16:29 In New Clinical Study Masimo’s Oxygen Reserve Index Helps Clinicians Detect Impending Desaturation in Pediatric Patients
2016-02-15 14:13 Quintiles Wins 2016 Leadership Excellence Award
2016-02-15 11:22 The European Society of Cardiology announces winners of innovative cardiovascular research grant programme
2016-02-05 16:12 Pharmaron Acquires Quotient Bioresearch
2016-02-05 11:06 Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full Year
2016-02-05 09:52 Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer® Antibody-Drug Conjugates and XMT-1522
2016-02-04 16:41 SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
2016-02-04 14:03 NAMSA Announces Divestiture of its Sterility Assurance Products Division
2016-02-04 05:00 The Health Industry Summit stirs investor frenzy over China’s healthcare sector with double-digit growth
2016-01-29 16:16 22nd Century Launches New RED SUN® Extremely Nicotine Website
2016-01-27 17:08 22nd Century Delivers 4.95 Million SPECTRUM® Cigarettes for the National Institute on Drug Abuse
2016-01-27 16:12 Boehringer Ingelheim’s Giotrif® / Gilotrif® (afatinib) demonstrated superiority to Iressa® (gefitinib) in reducing the risk of disease progression and treatment failure in first-line treatment of...
2016-01-25 18:04 European Commission Approves Label Variation for ADCETRIS® (Brentuximab Vedotin) to Include Data on Retreatment of Adult Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma (sALCL)
2016-01-25 16:32 Kyoto University and Panasonic Developed New Remote Sensing Technology for Vital Signs by Millimeter-wave Radar
2016-01-22 16:58 Pampers and UNICEF Mark the Impact of a 10-Year Public-Private Partnership at the World Economic Forum in Davos
2016-01-20 16:56 22nd Century Meets with FDA on Historic Modified Risk Tobacco Product Application for World’s Lowest Nicotine Tobacco Cigarettes

Business Wire Weibo

Press Releases

Latest Releases